343 related articles for article (PubMed ID: 16497164)
1. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle.
Hanisch F; Hellsten Y; Zierz S
Biol Chem; 2006 Jan; 387(1):53-8. PubMed ID: 16497164
[TBL] [Abstract][Full Text] [Related]
2. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.
Rico-Sanz J; Rankinen T; Joanisse DR; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C;
Physiol Genomics; 2003 Jul; 14(2):161-6. PubMed ID: 12783984
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I).
Tkacz-Stachowska K; Lechward K; Skladanowski AC
Acta Biochim Pol; 2005; 52(4):789-96. PubMed ID: 15940349
[TBL] [Abstract][Full Text] [Related]
4. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.
Roszkowska A; Klimek J; Kaletha K
Mol Cell Biochem; 2008 Apr; 311(1-2):249-51. PubMed ID: 18165923
[TBL] [Abstract][Full Text] [Related]
6. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
[TBL] [Abstract][Full Text] [Related]
8. Is the C34T polymorphism of the AMPD1 gene associated with athlete performance in rowing?
Ciȩszczyk P; Eider J; Ostanek M; Leońska-Duniec A; Ficek K; Kotarska K; Girdauskas G
Int J Sports Med; 2011 Dec; 32(12):987-91. PubMed ID: 22105616
[TBL] [Abstract][Full Text] [Related]
9. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle.
Norman B; Mahnke-Zizelman DK; Vallis A; Sabina RL
J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316
[TBL] [Abstract][Full Text] [Related]
10. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?
Pérez M; Martin MA; Cañete S; Rubio JC; Fernández-Moreira D; San Juan AF; Gómez-Gallego F; Santiago C; Arenas J; Lucia A
Int J Sports Med; 2006 Jun; 27(6):429-35. PubMed ID: 16767606
[TBL] [Abstract][Full Text] [Related]
11. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
[TBL] [Abstract][Full Text] [Related]
12. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
Fortuin FD; Morisaki T; Holmes EW
Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
[TBL] [Abstract][Full Text] [Related]
13. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
[TBL] [Abstract][Full Text] [Related]
14. AMPD1 genotypes and exercise capacity in McArdle patients.
Rubio JC; Pérez M; Maté-Muñoz JL; García-Consuegra I; Chamorro-Viña C; Fernández del Valle M; Andreu AL; Martín MA; Arenas J; Lucia A
Int J Sports Med; 2008 Apr; 29(4):331-5. PubMed ID: 17687759
[TBL] [Abstract][Full Text] [Related]
15. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
16. [Can mutation of the AMPD1 gene encoding human deaminase muscle muscle isozyme AMP be a prognostic marker of primary dilated cardiomyopathy?].
Kaletha K; Chodorowski Z; Nagel-Starczynowska G; Gazda M; Słomińska E
Postepy Biochem; 1999; 45(3):182-4. PubMed ID: 10761193
[No Abstract] [Full Text] [Related]
17. Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation.
Rybakowska I; Bakuła S; Klimek J; Milczarek R; Smolenski RT; Kaletha K
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):453-6. PubMed ID: 20544536
[TBL] [Abstract][Full Text] [Related]
18. Activity of 5'-nucleotidase, AMP deaminase, adenosine deaminase, acid and alkaline phosphatase and nucleotide pyrophosphatase in human thyroid.
Jaroszewicz L; Głowacka D; Stelmach H; Niedźwiecka J
Endocrinol Exp; 1985 Dec; 19(4):231-6. PubMed ID: 3002751
[TBL] [Abstract][Full Text] [Related]
19. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
[TBL] [Abstract][Full Text] [Related]
20. [Role of adenylate kinase, AMP deaminase and 5'-nucleotidase in the metabolism of adenylic nucleotides].
Litovchenko IN; Savitskiĭ IV
Biokhimiia; 1984 Aug; 49(8):1248-52. PubMed ID: 6093896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
